Not applicableStudy completedNCT02606851
What this trial is testing
Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.
Who this might be right for
Patients With Typical Symptoms of GERD (GERD Q >= 8)
AstraZeneca 1,000